Systemic lupus erythematosus (SLE) is a multifactorial autoimmune rheumatic disease. Although its highest prevalence is among women of childbearing age, the disease is not confined within this ...

Caring for children and teens with a chronic illness requires patience and an acceptance that certain life-style changes will have to be made. Additionally, you also have the responsibility of making ...

Andrea Knight, MD, MSCE, Clinician Investigator, Division of Rheumatology, Hospital for Sick Children, and Lupus Foundation of America Medical-Scientific Advisory Council member shared, "Obtaining ...

Following a lengthy R&D process, two new molecules from Biogen could add much-needed treatments for a disease that’s been ...

A cross-sectional study found that greater resilience, both on the individual and socio-ecological level, is linked to better mental health outcomes in individuals living with childhood-onset systemic ...

With this approval, pediatric patients aged five years and older with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration. GSK plc (LSE/NYSE: GSK) today ...

MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active ...

Lupus is associated with chronic morbidity and an increased risk of mortality, and has an unpredictable course. These features emphasize the need for long-term monitoring. Although broadly similar, ...

WASHINGTON, June 26, 2025 /PRNewswire/ -- This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year's recipients ...

Belimumab autoinjector is now approved and available for pediatric patients with lupus nephritis. The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for ...